Alkem Launches Novel Breast Cancer Treatment Drug Palbociclib (Palbo) in India
In a move that is likely to bring relief to a huge number of breast cancer patients, Alkem Oncology recently announced the launch of the breast cancer drug, Palbociclib under the brand name, Palbo. Palbo which contains Palbociclib, is recommended by the National Comprehensive Cancer Network (NCCN-2022) as a first-line treatment for individuals with metastatic […]
Continue Reading